Company intelligence / Profile preview

Ravgen

Columbia, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Ravgen has developed and commercialized non-invasive prenatal diagnostic tests using fetal DNA from maternal blood, including tests for chromosomal abnormalities (e.g., Down syndrome) and single gene disorders. These tests have been validated and published in major peer-reviewed journals, and the company holds foundational patents in this area[1][2][3][5].

Therapeutic areas: Women's HealthPulmonologyNeurologyRare DiseasesHematology
Modalities: Diagnostic testMolecular diagnostic
Industry: Molecular Diagnostics

Partnerships

Multiple laboratory partners in the United States (not specifically named)[2]

Beyond the preview

Go deeper on Ravgen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ravgen.

Explore the full profile